Henri Termeer, 71, former CEO of Genzyme – Boston Herald
About – Henri Termeer Legacy Timeline - The Termeer Foundation
Oral history interview with Henri Termeer - Science History Institute Digital Collections
Launching a Tribute to an Icon, Mentor & Friend — Henri A. Termeer Tribute
Chapter 3, Part 1: Orphan Drugs - by Christie Smythe
Angelos Georgakis on Twitter: "Biotech Leaders, Making a Drug is Not Enough! Joshua Boger, the founder of Vertex Pharmaceuticals writes about his mentor Henri Termeer: "Henri reminded me and challenged me and
Genzyme's Termeer Got $50M in Compensation Over Last 3 Years; Wife Got Trips to Asia on Corporate Jet - CBS News
Henri Termeer isn't exactly settling into retirement - The Boston Globe
Remembering Henri A. Termeer | American Academy of Arts and Sciences
Biotech pioneer and former Genzyme CEO Henri Termeer dies | Fierce Biotech
BioCentury - Henri: N of 1
77 Termeer Stock Photos, High-Res Pictures, and Images - Getty Images
HENRI TERMEER Obituary (2017) - Marblehead, MA - Boston Globe
Larger-than-life biotech figure Henri Termeer dies at 71 - MedCity News
Henri Termeer, 'giant of biotech' and longtime CEO of Genzyme, dies at 71 - Boston Business Journal
Harvard Business School's Baker Library Announces New Collection: John Hawkins Research Interviews about Henri Termeer, Longtime Chairman, CEO, and President of Genzyme Corporation - News - Harvard Business School
How Genzyme became a source of biotech executives - The Boston Globe
Henri Termeer, 71, former CEO of Genzyme – Boston Herald
MIT Corporation life member and biotech pioneer Henri Termeer dies at 71 | MIT News | Massachusetts Institute of Technology
Henri Termeer - Wikipedia
About – Henri Termeer Legacy Timeline - The Termeer Foundation
New Book Details Singular Life of Biotech Pioneer, UVA Darden Alumnus Henri Termeer – Darden Report Online
Former Genzyme CEO Henri Termeer co-founds biotech aimed at Parkinson's - Boston Business Journal
Henri Termeer, CEO Genzyme Corp, RIP | Boston Photographer Stanley Rowin
Henri Termeer's legacy is a vibrant biotech sector | Financial Times
